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Abstract 
Background 
The World Health Organization (WHO) Global Program to Eliminate Lymphatic 
Filariasis relies on mass drug administration (MDA) of two drugs annually for 4 to 6 
years. The goal is to reduce the reservoir of microfilariae in the blood to a level 
insufficient to maintain transmission by the mosquito vector. In 2008, the 
international medical aid organization Médecins Sans Frontières (MSF) performed the 
first round of a MDA in the high-burden area of Asmat district, in Papua, Indonesia. 
We report the challenges faced in this MDA on a remote Indonesian island and 
propose solutions to overcome these hurdles in similar future contexts. 
Results 
During the MDA, we encountered difficult challenges in accessing as well as 
persuading the patient population to take the antifilarial drugs. Health promotion 
activities supporting treatment need to be adapted and repetitive, with adequate time 
and resources allocated for accessing and communicating with local, seminomadic 
populations. Distribution of bednets resulted in an increase in MDA coverage, but it 
was still below the 80-85% target. 
Conclusions 
MDA for lymphatic filariasis is how the WHO has planned to eliminate the disease 
from endemic areas. Our programmatic experience will hopefully help inform future 
campaign planning in difficult-to-access, high-burden areas of the world to achieve 
target MDA coverage for elimination of lymphatic filariasis.   - 3 - 
Background 
Lymphatic filariasis (LF) is a parasitic disease transmitted by mosquito bites which 
causes disability and adversely impacts the economy of the developing countries 
where it is endemic. LF is the fourth most common cause of disability worldwide [1]. 
It is caused by Wuchereria bancrofti, Brugia malayi, or Brugia timori. These parasites 
reside in lymphatic channels or lymph nodes where they remain viable for more than 
two decades. W. bancrofti is the most widely distributed, affecting an estimated 115 
million people throughout the tropics and subtropics. The World Health Organization 
(WHO) estimates that 120 million people are currently infected and more than 1 
billion people are at risk in 83 countries [1]. Approximately 40 million people are 
seriously incapacitated and disfigured by the disease [1,2]. 
 
LF disease transmission can be stopped through a feasible, effective, and relatively 
inexpensive prevention strategy through mass drug administration (MDA) of two oral 
drugs to at-risk populations once a year [3-5]. These drugs kill the microfilariae in an 
infected patient’s blood so that mosquitoes cannot transmit the disease to others. This 
MDA-based strategy of transmission interruption is part of the WHO’s Global 
Program to Eliminate Lymphatic Filariasis [6]. 
 
Filariasis is an eradicable disease of high prevalence among several of the islands of 
Indonesia. Due to the high prevalence and remote distribution and diversity of filarial 
infections, filariasis elimination in Indonesia is a major challenge [7]. 
 
In 2008, the international medical aid organization Médecins Sans Frontières (MSF) 
offered to carry out the first round of a MDA in the district of Asmat, Papua,   - 4 - 
Indonesia, where LF was found to be endemic. We report here our experience and the 
challenges faced in this MDA against LF in Asmat over an 11-week period from July 
to September 2008. 
 
Results 
Outcomes of the MDA Campaign 
The first MSF filariasis campaign took place in Asmat District from July 9, 2008, the 
date of the first MDA activity, to September 22, 2008, date of the last MDA activity. 
All the 7 subdistricts were covered, comprising 147 villages visited over 28,000 km². 
 
A total of 36,478 people took the drug treatment, giving an average coverage of 58% 
of the targeted population. The teams spent a total of about 1,000 hours on boats, 
consuming a total of 24 tons of fuel, representing an average of 1.5 people treated per 
liter of fuel used in this campaign. 
 
Program Challenges 
Accessing and communicating with populations and workers 
Because of their remoteness, the villages were not often visited by outsiders and were 
accessible only by boat. No radio, television, or newspaper media exist, ruling out 
advertising educational campaigns through the mass media. Due to this difficulty of 
accessing local populations, villagers were visited by local health workers about once 
a month. Workers went to the villages a few weeks before the MDA campaign, and 
the upcoming campaign was mentioned. Attempts were sometimes made to send out 
dates of the MDA through the District Health Office (DHO), but these notices were 
often not distributed.   - 5 - 
 
Local health workers however did not perform much health promotion, with most of 
this task handled by MSF. For example, some puskesmas (local health center) staff 
did not receive invitations for training since postal service is nonexistent in the 
villages of Asmat, though radio communication to the puskesmas was present at 
times. Messages were often conveyed word-of-mouth and depended on the next boat 
that arrived from Agat, the capital. 
 
In the village of Yahoi in Fayit, there had been some deaths from snakebites the 
previous 2 years, and the villages asked for antivenom. Later, on the day of MDA, 
some villagers were agitated that MSF was treating filariasis in people who had no 
obvious signs of the disease, when they needed basic health care for diseases like 
malaria and diarrhea. The physician happened to be there to explain to the people that 
filariasis can be eradicated with these drugs, but means to eradicate malaria and 
diarrhea, for instance, have not been found yet. 
 
MSF faced program difficulties in Sawa Erma, the subdistrict with the largest 
population. Rumors in the subdistrict included, “you drown if you take the drugs” and 
“someone died in Agat after taking the drugs.” With the vastness of this subdistrict 
(Sawa Erma) and a little under 2 weeks allotted to it, we experienced a marked fall in 
drug administration compliance, averaging only 37% population coverage. 
Convincing the local population was difficult, as they had little trust in the MDA 
program. To try to remedy this, the village chief in Sawa took the drugs to 
demonstrate their safety (a practice often repeated throughout the campaign), but the   - 6 - 
people watching still would not register to take the drugs. Talking to reassure them 
was also not helpful. This difficulty was not encountered in other subdistricts. 
 
In other subdistricts, for instance in Atsy and Pantai Kasuari, where there was 
insufficient health care, people came to us and requested health care. Some people 
narrated the number of infant deaths from diarrhea in the previous year, or the high 
number of asthma cases in a village. When we explained that we were just working on 
filariasis in collaboration with the DHO, it was hard to gain trust. The population, 
rightly, had concerns about other diseases that were life-threatening. In the face of 
health care difficulties such as these, just telling the needy villagers we would pass the 
word along, and that our task here was only MDA, may have sounded superficial. 
This has been the experience in other MDA campaigns as well [8]. 
 
The village headmen were often absent, so finding a person the villagers trusted, who 
would help convince them, was also a challenge. Villagers were sometimes absent 
from villages, lowering coverage. The reasons given were “they have gone to Agat” 
or “they are in the forest looking for food.” Visits to bewaks (temporary river shelters) 
were not always fruitful since people were in the forest. 
 
Population numbers were often unreliable. The numbers provided by the DHO were 
projections from the 2000 census when Asmat was still part of the district of 
Merauke. No newer numbers were available at the time of the intervention. These 
numbers were found to be inflated when one talked to village authorities and tallied 
numbers. For instance, in the village of Yomoth, our population figure was 647, the 
village head told us 502, and a village elder told us only about 300 people actually   - 7 - 
lived in the village. A total of 180 people were treated with the drugs. Drug coverage 
could not therefore be accurately determined. 
 
One or two hours of health promotion, depending on village size, was not always 
sufficient to convince people of the importance of taking the drugs. Establishing trust 
took more time and effort than anticipated. 
 
Mapping of bewaks 
No maps were available indicating each village’s bewaks, probably because they are 
temporary structures. But accessing people living in bewaks was crucial to the success 
of a campaign of this nature, which necessitates high coverage. Knowing the locations 
of bewaks was difficult, especially in the largest subdistrict of Sawa Erma. 
Information on bewaks was not available, nor attempted to be obtained, at the time of 
MDA planning. Exploration was not done in this subdistrict since mobile clinics had 
been conducted here, but the populations who came for mobile clinics had sought 
medical attention for other ailments. 
 
The bewaks tended to be scattered and only villagers could take us to them, 
something not factored into the time frame of the campaign. In the time table for the 
campaign, one day was allotted for each village of a subdistrict. To return to base by 
5:00 PM, a team may sometimes have to leave 2 hours beforehand, and that left no 
time to visit a large portion of the populations in bewaks. Also, bewaks were often 
inaccessible even when there was time to visit them for drug distribution. 
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Treatment incentives 
Population turnout and compliance was best in the 4 subdistricts where bednets were 
distributed (Table 1). People often rowed long distances from bewaks and even came 
to our base village to take drugs when these people had been absent at the time of 
drug distribution in villages.  
 
Staying overnight in villages after drug distribution so adverse events could be 
examined and treated helped increase compliance. The adverse events noted were 
fever, nausea, and vomiting. When the team could stay on a little later after the end of 
drug distribution (being close to or in the base village), people’s questions were 
answered, and adverse events could be ascertained and treated appropriately. 
 
Discussion 
Lessons Learned 
Lessons learned to potentially apply to future MDA campaigns include: 
1.  In remote locations with no media presence and with the difficulty of 
transportation to remote villages and their bewaks, accurate mapping must be 
carried out first. 
2.  Adequate time must be allocated for studying the populations and devising 
effective health promotion techniques in collaboration with local health 
authorities and respected figures in the area. Such feedback is crucial. Visiting 
villages at least once before the start of the campaign to introduce it, meeting 
with village elders and establishing rapport, and returning to repeat and 
announce the campaign date may be effective strategies.   - 9 - 
3.  Adequate time must be allotted to the actual MDA campaign so that (a) 
geographically most if not all the population can be reached; (b) villages can 
be revisited, if possible, to allow time for people to come from places such as 
bewaks; (c) lessons learned from villages covered early on in the campaign 
can be applied meaningfully to villages visited later; and (d) unforeseen events 
such as inappropriate weather or fuel shortages can be dealt with easily. 
4.  Incentives to the LF-affected populations may be useful in improving 
compliance. These can be materials (eg, bednets) or human resources (eg, 
holding free clinics to treat other ailments if time permits).  
5.  Polyvalent teams are more efficient (for both health promotion and MDA 
activities): 
•  The same team should do health promotion and MDA activities in one 
village 
•  Optimal team is composed of one nurse, one health promoter, and one 
logistician 
•  About 1.5 hours needed for health promotion activity in one village. 
•  A MDA team (3 people) can cover approximately 60 patients/hour 
(suitable for a village), up to 500 people/day 
6.  Local people within the staff can help reassure the populations during MDA 
 
Strategies for Accessing Hard-to-Reach Populations 
Reaching the seminomadic populations in Asmat for LF MDA was a challenge, as 
was convincing people to take the drugs. Coupled with remoteness of location, and no 
readily utilizable mass media, an effective MDA requires sufficient time, repeat visits, 
and high emphasis on health promotion and establishing trust with local populations.   - 10 - 
Eliciting direct help and guidance from local, respected, high-standing villagers and 
sometimes missionaries and local pastors can be useful. Taking the necessary time 
and effort to establish understanding and trust should be borne out in future MDA 
campaigns. Coupled incentives to populations, such as distributing bednets, may help 
increase compliance. 
 
Conclusions 
Preventative MDA for a disease such as filariasis, which is chronic and has seemingly 
little effect on day-to-day life, is a major challenge. Filariasis affects parts of the 
world that are not industrialized and where people may not be generally aware of 
disease risk. Since MDA is done among the general population, the majority of whom 
have no symptoms of filariasis, compliance is the major hurdle. In this experience, 
when bednets were given with the drugs, compliance increased, indicating the 
potential importance of such incentives to populations when a non-life-threatening 
disease such as filariasis is targeted for intervention. 
 
Methods 
Intervention Setting and Characteristics 
Papua is the second largest island in the world and is governed by two countries: 
Papua New Guinea in the east and Indonesia in the west. The district of Asmat in 
western Papua has an area of about 28,000 km
2 and population of over 75,000. Asmat 
district has 7 subdistricts: Agats, Akat, Sawa Erma, Suator, Atsy, Fayit, and Pantai 
Kasuari.  
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MSF provided mobile clinics in Agats, Akat, and Sawa Erma from 2006 to 2008. 
MSF staff were based in Agat, the center of Agats and the capital of Asmat, and in the 
village of Pos in Sawa Erma (Figure 1). The MDA was carried out in the following 
order: Agats to Akat to Sawa Erma, and then Atsy, Suator, Fayit, and Pantai Kasuari. 
 
Off the Arafura Sea, Asmat district is remote, with access to villages only by boat via 
rivers that jut inland. The area is mainly swamp land and lacks electricity, roads, 
agriculture, and other modern facilities. The population is relatively poor and 
primarily has a middle-school level of education, with men tending to be educated at a 
higher level than the women. Fishing and foraging for wood for trade are the main 
occupations.  
 
The village population is divided between the actual village, and bewaks, temporary 
shelters built on rivers where groups of villagers go for a few months each year to 
forage in the forest for food and wood (Figure 2). Bewaks belong to particular 
villages. Families travel in kolekole, which are dug-out, narrow, long wooden canoes 
typically rowed by two people (Figure 3). 
 
Local health care is offered in the form of health centers called puskesmas, with one 
each in a subdistrict capital, and village health posts called pustus, run by a nurse 
and/or midwife. The DHO (also known as Dinas Kesehatan) is based in Agat, the 
district capital. 
 
Beginning in November 2006 over 2 years, MSF helped provide basic health care 
through mobile clinics. In February 2008, MSF launched a study comparing the   - 12 - 
performance of three malaria rapid diagnostic tests with that of microscopy (gold 
standard). A total of 492 patients were included in this study from 3 subdistricts 
(Sawa Erma, Agats, and Akat) in which 245 (49.8%) were children under 5 years of 
age. Most of the patients came from Sawa Erma (60.2%). Microfilariae were found 
among 10 patients: 6 positive for W. bancrofti, 2 positive of B. malayi, and 2 mixed 
between W. bancrofti and B. malayi. All were from Sawa Erma subdistrict in 5 
villages (Bu Agani, Aou, Kappi, Weo, and Mumugu), which confirmed the clinical 
findings. The microfilaria rate was thus 2.03%, which exceeds the criteria of the 
Ministry of Health (MOH) and WHO (≥1%) to declare an area as endemic [9]. 
 
In Asmat, both limb elephantiasis and hydrocele (enlargement of the scrotum with 
fluid due to obstruction of lymphatic drainage by the worm) are symptomatic 
manifestations of chronic filariasis. Occasionally, unilateral breast enlargement has 
also been observed. 
 
Because the district did not have the required budget to carry out a MDA campaign 
for filariasis, in 2008 MSF offered to perform the first round of MDA. The MOH and 
DHO committed to continuing the campaign for the remaining four rounds over the 
following 4 years. 
 
Medical and Health Promotion Teams and Strategy 
The filariasis MDA team was comprised of one field coordinator, one physician 
(medical coordinator), 4 nurses, and 8 health promoters, in addition to the logistics 
staff (Figure 4). The medical teams were comprised of one nurse, one health 
promoter, a logistician, and a boat driver. The health promotion teams each had two   - 13 - 
health promoters and a boat driver. The complete MDA team of initially 27 people 
was expanded to 29 to cover the last 2 subdistricts. 
 
The health promotion team traveled to villages and spoke with the village chief or 
another respected person. They then gathered the villagers at a common place and 
introduced themselves, and described filariasis and the importance of eradicating it. 
The team explained that all villagers (except pregnant and lactating women, persons 
with ongoing fever, and the chronically ill) would be given three drugs for this 
purpose, two to treat the active and nascent disease (albendazole and 
diethylcarbamazine) and the third (paracetamol) to reduce side effects. The team used 
flip charts and leaflets as educational aids, and hung posters explaining the disease 
cycle and drugs in simple terms. In subdistricts where MSF had not worked before, 
MSF newsletters were given to the village chief. 
 
Written materials were in Bahasa Indonesia, the national language of Indonesia. The 
team used microphones to walk around the village announcing the day of the MDA 
campaign, along with the venue advised by the village elders. The team met with 
midwives and/or kaders (community health workers) to help with registrations. 
 
One to three days after the health promotion team visited a village (except in the 
largest subdistrict of Sawa Erma, where longer time sometimes elapsed between 
health promotion and MDA activities), the MDA team arrived in the morning, set up 
base at the decided venue, briefly described the disease and treatment again, and 
proceeded to start MDA. When turnout was low, the team sometimes went door to 
door. Also, in such cases, they went to the bewaks close by, if accessible. The team   - 14 - 
was required to leave at a time that would allow them to return to the team base by 
5:00 PM (since the boats did not have adequate equipment for navigation in the dark). 
The base was the central village where all the teams stayed while MDA was done in 
one subdistrict. 
 
At the end of each subdistrict, sweeping (the process of returning to a population with 
drugs where adequate coverage was not accomplished the first time) was done in 4 
villages with the least coverage on the original MDA day. As an ancillary to the 
MDA, registration of hydrocele in men and malnutrition in children 2-5 years old was 
performed. At the end of the campaign, hydrocele repair was to be planned. This was 
done a few months after the end of the MDA campaign. 
 
In the subdistricts of Atsy, Suator, Fayit, and Pantai Kasuari, one bednet was given to 
each family administered drugs. Villagers were informed of this distribution on the 
day of health promotion, and it was made clear that bednets were not a cure for 
filariasis, but helped prevent malaria and could help with filariasis prevention to some 
degree as well. The bednets had already been distributed for malaria prevention in the 
other subdistricts over the last 2 years since MSF had had a presence there. 
 
Health Worker Training 
Conducted by MSF, this first round of the MDA campaign was a collaboration with 
the DHO. Two doctors from the MOH arrived from Jakarta to help in the training of 
local health and MSF staff. Doctors from the 7 puskesmas of Asmat were invited, as 
were some ancillary health staff. 
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The training lasted one day and covered: 
•  History of MSF in the area and our past activities 
•  How MSF decided to carry out the first round of MDA 
•  MOH policy for implementing the filariasis program 
•  Pathophysiology, symptoms, diagnosis, complications, prevention, and 
treatment of filariasis in the international context 
•  Filariasis in Asmat 
•  Health promotion strategies 
•  MDA organization at health center level 
•  Demonstration of drug distribution and MDA technique 
•  Adverse reactions of drugs (minimal and minor) 
•  Methods of reporting drug administration coverage 
•  Security guidelines 
 
Health promotion training involved educating the patient populations of the ancillary 
effects of the filariasis drugs, such as the elimination of intestinal helminths and 
decreases in infant and maternal morbidity. Training of MSF staff was reinforced 
after 5 subdistricts were completed. Training was also improvised as we encountered 
patients who complained of limb pain, fever, and itching after drug treatment. The 
patients were told, for instance, that if adverse events were encountered, it meant the 
drugs were working (so they would not assume the drugs were making them sick and 
pass that on to other villagers), and to seek treatment for adverse events in the local 
health centers. 
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Figures 
Figure 1. Map of Asmat district 
 
Figure 2. Bewak 
Credit: Navneet Bhullar/MSF 
 
Figure 3. Kolekole 
Credit: Navneet Bhullar/MSF 
 
Figure 4. Filariasis MDA team organizational chart, Asmat district, Papua, 
Indonesia, 2008 
MDA, mass drug administration; HP, health promotion   - 19 - 
Tables 
Table 1. Population coverage of filariasis MDA in 7 subdistricts of Asmat 
district, Papua, Indonesia, 2008 
 
Subdistrict  Total 
population* 
Target 
population
† 
MDA coverage,* 
n (%) 
Bednets used 
Agats
‡  8349  6679  5207 (78.0)  0 
Akat  6465  5172  2964 (57.3)  0 
Sawa Erma  15,204  12,169  4263 (35.0)  0 
Suator  8139  6511  3958 (60.8)  1404 
Atsy  14,867  11,894  7730 (65.0)  2444 
Fayit  6939  5551  4085 (73.6)  1295 
Pantai Kasuari  16,147  12,918  7751 (60.0)  2400 
TOTAL  76,110  60,893  35,958 (59.1)  7543 
 
MDA, mass drug administration 
 
*Only villages originally planned for MDA coverage and reached were included in 
this analysis. 
 
†Target population calculated as 80% of total population. 
 
‡In Agats subdistrict, the village of Bis Agats received multiple sweeping rounds 
(since it was near MSF headquarters and thus most accessible) and numerous visitors 
from neighboring villages, resulting in very high coverage (157%) that could possibly 
skew the overall coverage picture of Agats. If Bis Agats is excluded, then total 
population = 5758, target population = 4606, coverage n = 1952, and % coverage = 
42.4%. 
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